A pandemic hasn’t stopped some pharma companies from implementing their traditional mid-year price hikes.
AstraZeneca, for instance, raised prices on 21 medicines from 1.5% to 6% this month, GoodRx reports. But while the U.K.-based company increased stickers on far more medicines than its peers did in July, it wasn't alone. Eli Lilly, Sanofi, GlaxoSmithKline and Biogen each raised prices on one or two of their medicines.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,